103 related articles for article (PubMed ID: 15572539)
1. Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis.
Miotto D; Boschetto P; Bononi I; Zeni E; Cavallesco G; Fabbri LM; Mapp CE
Eur Respir J; 2004 Dec; 24(6):958-63. PubMed ID: 15572539
[TBL] [Abstract][Full Text] [Related]
2. Alterations of vasoactive intestinal polypeptide receptors in allergic rhinitis.
Kim DH; Park IH; Cho JS; Lee YM; Choi H; Lee HM
Am J Rhinol Allergy; 2011; 25(1):e44-7. PubMed ID: 21711977
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis.
Guddo F; Vignola AM; Saetta M; Baraldo S; Siena L; Balestro E; Zuin R; Papi A; Maestrelli P; Fabbri LM; Bonsignore G; Turato G
Eur Respir J; 2006 May; 27(5):957-63. PubMed ID: 16510460
[TBL] [Abstract][Full Text] [Related]
4. Activation of the vasoactive intestinal peptide 2 receptor modulates normal and atrophying skeletal muscle mass and force.
Hinkle RT; Donnelly E; Cody DB; Sheldon RJ; Isfort RJ
J Appl Physiol (1985); 2005 Feb; 98(2):655-62. PubMed ID: 15649881
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients.
Burian B; Storka A; Marzluf BA; Yen YC; Lambers C; Robibaro B; Vonbank K; Mosgoeller W; Petkov V
Peptides; 2010 Apr; 31(4):603-8. PubMed ID: 20026142
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate.
Asnicar MA; Köster A; Heiman ML; Tinsley F; Smith DP; Galbreath E; Fox N; Ma YL; Blum WF; Hsiung HM
Endocrinology; 2002 Oct; 143(10):3994-4006. PubMed ID: 12239111
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
García-Fernández MO; Collado B; Bodega G; Cortés J; Ruíz-Villaespesa A; Carmena MJ; Prieto JC
Gynecol Endocrinol; 2005 Jun; 20(6):327-33. PubMed ID: 16019382
[TBL] [Abstract][Full Text] [Related]
8. Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide.
Voice JK; Dorsam G; Chan RC; Grinninger C; Kong Y; Goetzl EJ
Regul Pept; 2002 Nov; 109(1-3):199-208. PubMed ID: 12409234
[TBL] [Abstract][Full Text] [Related]
9. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation.
Saetta M; Turato G; Baraldo S; Zanin A; Braccioni F; Mapp CE; Maestrelli P; Cavallesco G; Papi A; Fabbri LM
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):1016-21. PubMed ID: 10712357
[TBL] [Abstract][Full Text] [Related]
10. Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors.
Groneberg DA; Rabe KF; Fischer A
Eur J Pharmacol; 2006 Mar; 533(1-3):182-94. PubMed ID: 16473346
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide expression in the airways of COPD patients and smokers with normal lung function.
Vatrella A; Montagnani S; Calabrese C; Parrella R; Pelaia G; Biscione GL; Corcione N; Marsico SA; Guerra G
J Biol Regul Homeost Agents; 2010; 24(4):425-32. PubMed ID: 21122281
[TBL] [Abstract][Full Text] [Related]
12. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
13. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-13 and -4 expression in the central airways of smokers with chronic bronchitis.
Miotto D; Ruggieri MP; Boschetto P; Cavallesco G; Papi A; Bononi I; Piola C; Murer B; Fabbri LM; Mapp CE
Eur Respir J; 2003 Oct; 22(4):602-8. PubMed ID: 14582911
[TBL] [Abstract][Full Text] [Related]
16. Mucociliary clearance and airways obstruction in smokers, ex-smokers and normal subjects who never smoked.
Vastag E; Matthys H; Köhler D; Gronbeck L; Daikeler G
Eur J Respir Dis Suppl; 1985; 139():93-100. PubMed ID: 3862617
[TBL] [Abstract][Full Text] [Related]
17. Gene expression of vasoactive intestinal peptide receptors in human lung cancer.
Szilasi M; Buglyo A; Treszl A; Kiss L; Schally AV; Halmos G
Int J Oncol; 2011 Oct; 39(4):1019-24. PubMed ID: 21769421
[TBL] [Abstract][Full Text] [Related]
18. [A clinical study on determination of plasma vasoactive intestinal peptide and the relationship between plasma vasoactive intestinal peptide and bronchial responsiveness in asthmatics].
Liu A; Li PS; Zhang ZJ
Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):165-6. PubMed ID: 8222979
[TBL] [Abstract][Full Text] [Related]
19. Duplicated receptors for VIP and PACAP (VPAC1R and PAC1R) in a teleost fish, Fugu rubripes.
Cardoso JC; Power DM; Elgar G; Clark MS
J Mol Endocrinol; 2004 Oct; 33(2):411-28. PubMed ID: 15525598
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves.
Fahrenkrug J; Hannibal J; Tams J; Georg B
J Cereb Blood Flow Metab; 2000 Aug; 20(8):1205-14. PubMed ID: 10950381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
